Clinical Outcome of Hypomethylating Agents in Hypocellular MDS: Mayo Clinic Experience

被引：0
|
作者：
Cerquozzi, Sonia [1 ]
Alkhateeb, Hassan B. [1 ]
Binder, Moritz [2 ]
Zblewski, Darci [1 ]
Hashmi, Shahrukh K. [1 ]
Patnaik, Mrinal M. [1 ]
Hogan, William J. [1 ]
Litzow, Mark R. [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Dept Internal Med, Rochester, MN USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] CLINICAL PRESENTATION AND OUTCOME OF AUTOIMMUNE HEMOLYTIC ANEMIA IN THE PEDIATRIC POPULATION; EXPERIENCE AT MAYO CLINIC
    Sankaran, Janani
    Rodriguez, Vilmarie
    Kreuter, Justin
    Jacob, Eapen
    Go, Ronald
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 39 - 39
  • [12] Long-Term Outcome of Patients with Myelodysplastic Syndromes (MDS) Treated with Hypomethylating Agents (HMA): A Report on Behalf of the MDS Clinical Research Consortium
    Jabbour, Elias
    Sasaki, Koji
    Sekeres, Mikkael A.
    Komrokji, Rami S.
    Steensma, David P.
    DeZern, Amy E.
    Gail, Roboz J.
    Daver, Naval G.
    Pemmaraju, Naveen
    Kadia, Tapan
    DiNardo, Courtney D.
    Wang, Xuemei
    Nogueras-Gonzalez, Graciela
    Borthakur, Gautam
    Estrov, Zeev
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [13] Oral hypomethylating agents: beyond convenience in MDS
    Griffiths, Elizabeth A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 439 - 447
  • [14] Paratesticular masses: A clinical perspective, the Mayo Clinic experience
    Tsao, Alice K.
    Kames, Jeffrey
    Sebo, Thomas J.
    Nehra, Ajay
    JOURNAL OF UROLOGY, 2007, 177 (04): : 196 - 197
  • [15] Leveraging Hypomethylating Agents for Better MDS Therapy
    Bradley, Terrence J.
    Watts, Justin M.
    Swords, Ronan T.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 507 - 515
  • [16] Leveraging Hypomethylating Agents for Better MDS Therapy
    Terrence J. Bradley
    Justin M. Watts
    Ronan T. Swords
    Current Hematologic Malignancy Reports, 2018, 13 : 507 - 515
  • [17] The euphoria of hypomethylating agents in MDS and AML: Is it justified?
    Sekeres, Mikkael A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (03) : 275 - 278
  • [18] Clinical outcome of home parenteral nutrition: The Mayo Clinic's twenty-year experience
    Scolapio, JS
    Fleming, CR
    Kelly, DG
    Wick, D
    Zinsmeister, AR
    GASTROENTEROLOGY, 1998, 114 (04) : A907 - A907
  • [19] The long-term outcome of Sezary syndrome: The Mayo Clinic experience
    Kubica, Agnieszka W.
    Weaver, Amy L.
    Davis, Mark D. P.
    Pittelkow, Mark R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB140 - AB140
  • [20] Differential Response to Hypomethylating Agents Based on Sex: A Report on Behalf of the MDS Clinical Research Consortium (MDS CRC)
    DeZern, Amy E.
    Zeidan, Amer M.
    Barnard, John
    Hand, Wesley
    Al Ali, Najla
    Brown, Francis
    Zimmerman, Cassie
    Roboz, Gail J.
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    Steensma, David P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
12345